Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Amgen Inc.

Capitalization 197B 172B 156B 149B 270B 18,227B 280B 1,850B 735B 8,720B 741B 725B 31,453B P/E ratio 2026 *
24.6x
P/E ratio 2027 * 22.7x
Enterprise value 237B 206B 187B 178B 324B 21,878B 336B 2,221B 883B 10,467B 889B 871B 37,754B EV / Sales 2026 *
6.26x
EV / Sales 2027 * 5.95x
Free-Float
99.85%
Yield 2026 *
2.74%
Yield 2027 * 2.93%
1 day+0.01%
1 week-2.84%
Current month-5.64%
1 month-0.80%
3 months+12.09%
6 months+34.12%
Current year+11.90%
1 week 364.72
Extreme 364.72
380.14
1 month 361.4
Extreme 361.395
391.29
Current year 318.21
Extreme 318.21
391.29
1 year 261.43
Extreme 261.43
391.29
3 years 211.71
Extreme 211.71
391.29
5 years 198.64
Extreme 198.64
391.29
10 years 133.64
Extreme 133.64
391.29
Manager TitleAgeSince
Chief Executive Officer 63 30/04/2012
Director of Finance/CFO 67 31/12/2019
Chief Operating Officer 59 24/07/2016
Director TitleAgeSince
Chairman 63 31/12/2012
Director/Board Member 65 31/12/2011
Director/Board Member 71 31/12/2011
Change 5d. change 1-year change 3-years change Capi.($)
+0.01%-2.84%+16.75%+56.14% 197B
+0.41%-1.91%+21.59%+200.16% 884B
+0.69%+0.25%+49.37%+57.88% 586B
+0.81%-2.64%+4.57%+42.59% 392B
+0.50%-3.04%+5.40%+23.34% 326B
+0.50%-1.45%+21.32%+33.55% 296B
+0.44%-0.05%+23.67%+59.94% 294B
-0.16%-1.43%+22.06%+7.54% 285B
+0.15%-0.97%+30.30%+81.85% 180B
+0.40%+1.15%-54.18%-48.90% 169B
Average +0.33%-1.86%+14.08%+51.41% 360.98B
Weighted average by Cap. +0.32%-1.71%+19.59%+78.21%

Financials

2026 *2027 *
Net sales 37.84B 32.96B 29.84B 28.47B 51.79B 3,494B 53.7B 355B 141B 1,671B 142B 139B 6,029B 38.73B 33.74B 30.55B 29.14B 53.01B 3,576B 54.96B 363B 144B 1,711B 145B 142B 6,170B
Net income 8.05B 7.01B 6.34B 6.05B 11.01B 743B 11.42B 75.39B 29.96B 355B 30.19B 29.55B 1,282B 8.74B 7.61B 6.89B 6.57B 11.96B 807B 12.4B 81.87B 32.53B 386B 32.79B 32.09B 1,392B
Net Debt 39.55B 34.45B 31.19B 29.76B 54.13B 3,651B 56.12B 371B 147B 1,747B 148B 145B 6,301B 32.96B 28.71B 25.99B 24.8B 45.11B 3,043B 46.77B 309B 123B 1,456B 124B 121B 5,250B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
16/03/26 366.25 $ +0.01% 2,099,105
13/03/26 366.21 $ -0.43% 1,500,319
12/03/26 367.79 $ -2.61% 1,990,663
11/03/26 377.64 $ +0.59% 2,300,019
10/03/26 375.43 $ -0.41% 2,284,548
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
366.25USD
Average target price
350.03USD
Spread / Average Target
-4.43%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW